U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H15N3O2
Molecular Weight 293.3199
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MPT0G-211

SMILES

ONC(=O)C1=CC=C(CNC2=CC=CC3=CC=CN=C23)C=C1

InChI

InChIKey=BPDQUKCPNSRTTR-UHFFFAOYSA-N
InChI=1S/C17H15N3O2/c21-17(20-22)14-8-6-12(7-9-14)11-19-15-5-1-3-13-4-2-10-18-16(13)15/h1-10,19,22H,11H2,(H,20,21)

HIDE SMILES / InChI

Molecular Formula C17H15N3O2
Molecular Weight 293.3199
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 19:41:41 GMT 2025
Edited
by admin
on Wed Apr 02 19:41:41 GMT 2025
Record UNII
NF3LL97ZD3
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MPT-0G211
Preferred Name English
MPT0G-211
Code English
Benzamide, N-hydroxy-4-[(8-quinolinylamino)methyl]-
Systematic Name English
N-Hydroxy-4-[(8-quinolinylamino)methyl]benzamide
Systematic Name English
Code System Code Type Description
PUBCHEM
132157820
Created by admin on Wed Apr 02 19:41:41 GMT 2025 , Edited by admin on Wed Apr 02 19:41:41 GMT 2025
PRIMARY
FDA UNII
NF3LL97ZD3
Created by admin on Wed Apr 02 19:41:41 GMT 2025 , Edited by admin on Wed Apr 02 19:41:41 GMT 2025
PRIMARY
CAS
2151853-97-1
Created by admin on Wed Apr 02 19:41:41 GMT 2025 , Edited by admin on Wed Apr 02 19:41:41 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Selectivity greater than 4,000~43,000-fold over other HDAC isoforms.
IC50
Name Property Type Amount Referenced Substance Defining Parameters References
BRAIN/PLASMA RATIO PHARMACOKINETIC